 
 
EXPLANATION:  CAPITALS INDICATE MAT TER ADDED TO EXISTIN G LAW . 
        [Brackets ] indicate matter deleted from existing law.  
         Underlining  indicates amendments to bill.  
         Strike out  indicates matter stricken from the bill by amendment or deleted from the la w by 
amendment.             *sb0224*      
SENATE BILL 224  
J1   5lr0265  
  (PRE –FILED)  CF HB 94  
By: Chair, Finance Committee (By Request – Departmental – Health)  
Requested: October 6, 2024  
Introduced and read first time: January 8, 2025  
Assigned to: Finance  
Committee Report: Favorable  
Senate action: Adopted  
Read second time: January 24, 2025  
 
CHAPTER ______  
 
AN ACT concerning  1 
 
Opioid–Associated Disease Prevention and Outreach Programs – Appeals and 2 
Membership of Standing Advisory Committee  3 
 
FOR the purpose of  authorizing a local health department or community –based 4 
organization to appeal to the Secretary of Health or the Secretary’s designee , rather 5 
than to the Deputy Secretary for Public Health Services, an adverse decision of the 6 
Maryland Department of Health and a local health officer regarding an application 7 
for authorization to operate an Opioid –Associated Disease Prevention and Outreach 8 
Program; alterin g the membership of the Standing Advisory Committee on  9 
Opioid –Associated Disease Prevention and Outreach Programs ; and generally 10 
relating to Opioid –Associated Disease Prevention and Outreach Programs . 11 
 
BY repealing and reenacting, without amendments,  12 
 Article – Health – General  13 
Section 24 –901(a) and (f)  14 
 Annotated Code of Maryland  15 
 (2023 Replacement Volume and 2024 Supplement)  16 
 
BY repealing and reenacting, with amendments,  17 
Article – Health  – General  18 
Section 24 –902, 24 –904, and 24 –905 19 
Annotated Code of Ma ryland  20 
(2023 Replacement Volume and 202 4 Supplement)  21 
 
2 SENATE BILL 224   
 
  SECTION 1. BE IT ENACTED BY THE GENERAL ASSEMBLY OF MARYLAND, 1 
That the Laws of Maryland read as follows:  2 
 
Article  – Health – General  3 
 
24–901. 4 
 
 (a) In this subtitle the following words have the meanings indicated.  5 
 
 (f) “Program” means an Opioid –Associated Disease Prevention and Outreach 6 
Program.  7 
 
24–902. 8 
 
 (a) (1) A Program may be established by a local health department or a 9 
community –based organization, subject to the provisions of this subtit le. 10 
 
  (2) (i) A county may cooperate with another county to establish a 11 
Program.  12 
 
   (ii) A community –based organization may establish a multicounty 13 
Program.  14 
 
  (3) This subtitle does not apply to the AIDS Prevention Sterile Needle and 15 
Syringe Exchange Pi lot Program established under Subtitle 8 of this title.  16 
 
 (b) (1) (i) A local health department or community –based organization 17 
shall apply to the Department and a local health officer for authorization to operate a 18 
Program.  19 
 
   (ii) A local health departm ent or community –based organization 20 
may apply at any time for authorization to operate a Program under subparagraph (i) of 21 
this paragraph.  22 
 
  (2) The Department and a local health officer jointly shall issue an 23 
authorization determination based on the ability of a Program to meet the requirements of 24 
this subtitle.  25 
 
  (3) The Department and a local health officer shall:  26 
 
   (i) Approve or deny an application for authorization to operate a 27 
Program within 60 days after receiving a complete application; and  28 
 
   (ii) Provide to the applicant a written explanation of the decision of 29 
the Department and local health officer.  30 
 
 SENATE BILL 224  3 
 
   (4) (i) A local health department or community –based organization 1 
may appeal an adverse decision by the Department and a local health officer to the 2 
[Deputy ] Secretary [for Public Health Services ] OR THE SECRETARY ’S DESIGNEE . 3 
 
   (ii) The [Deputy ] Secretary OR THE  SECRETARY ’S DESIGNEE  4 
shall:  5 
 
    1. Grant or deny an appeal within 60 days after receiving an 6 
appeal; and  7 
 
    2. Provide a written explanation of the [Deputy ] Secretary’s  8 
OR THE SECRETARY ’S DESIGNEE ’S decision to the local health department or 9 
community –based organization.  10 
 
 (c) If established under subsection (a) of this section, a Program shall:  11 
 
  (1) Provide for substance use outreach, education, and linkage to treatment 12 
services to participants, i ncluding distribution and collection of hypodermic needles and 13 
syringes; and  14 
 
  (2) Operate in accordance with:  15 
 
   (i) The technical assistance of the Standing Advisory Committee; 16 
and 17 
 
   (ii) The procedures, plans, and protocols approved by:  18 
 
    1. The local health officer for each county in which a Program 19 
is established; and  20 
 
    2. The Department.  21 
 
24–904. 22 
 
 (a) The Department shall appoint a Standing Advisory Committee on  23 
Opioid –Associated Disease Prevention and Outreach Programs.  24 
 
 (b) The Standing  Advisory Committee shall consist of:  25 
 
  (1) The [Deputy ] Secretary [for Public Health Services ] OR THE 26 
SECRETARY ’S DESIGNEE ; 27 
 
  (2) One individual from academia who specializes in public health issues 28 
related to substance –related disorders or infectious diseases;  29 
 
4 SENATE BILL 224   
 
   (3) One representative from law enforcement, nominated by the Executive 1 
Director of the Governor’s Office of Crime Prevention  and Policy ; 2 
 
  (4) One individual with expertise in the prevention of HIV or viral 3 
hepatitis;  4 
 
  (5) One health care practitioner with experience providing services to 5 
individuals who inject drugs;  6 
 
  (6) One individual with substance use experience;  7 
 
  (7) One family member of an individual who injects or has injected drugs;  8 
 
  (8) One representative of local law enforc ement;  9 
 
  (9) One local health officer;  10 
 
  (10) One representative of a local or regional hospital;  11 
 
  (11) One individual with experience in syringe services programs; and  12 
 
  (12) Any additional members recommended by the Department.  13 
 
 (c) The [Deputy ] Secretary [for Public Health Services ] OR THE SECRETARY ’S 14 
DESIGNEE  shall serve as chair of the Standing Advisory Committee.  15 
 
 (d) The Standing Advisory Committee shall:  16 
 
  (1) Provide technical assistance to each Program on developing:  17 
 
   (i) Program oper ating procedures for collection and distribution of 18 
hypodermic needles and syringes;  19 
 
   (ii) A plan for community outreach and education; and  20 
 
   (iii) A protocol for linking Program participants to substance –related 21 
disorder treatment and recovery servic es; and  22 
 
  (2) Make recommendations to a Program regarding any aspect of Program 23 
procedures or operation.  24 
 
24–905. 25 
 
 (a) The Department shall:  26 
 
 SENATE BILL 224  5 
 
   (1) Adopt regulations for the implementation of this subtitle, in 1 
consultation with the Standing Advisory Committee and the Maryland Association of 2 
County Health Officers; and  3 
 
  (2) Ensure the provision of technical assistance to a Program about best 4 
practices, best practice protocols, and other subject areas.  5 
 
 (b) The regulations adopted under subsection (a)(1) of this section shall establish:  6 
 
  (1) Procedures for ensuring the security of Program locations and 7 
equipment;  8 
 
  (2) An appeals process for appeals authorized by § 2 4–902(b)(4) of this 9 
subtitle, including the standard of review that the [Deputy ] Secretary [for Public Health 10 
Services ] OR THE SECRETARY ’S DESIGNEE  must apply when reviewing a decision of the 11 
Department and a local health officer; and  12 
 
  (3) Procedures for data collection and Program evaluation.  13 
 
 SECTION 2. AND BE IT FURTHER ENACTED, That this Act shall take effect July 14 
1, 2025.  15 
 
 
 
 
Approved:  
________________________________ ________________________________ ________________   
           Governor.  
________________________________ ________________________________ ________________   
                 President of the Senate.  
________________________________ ________________________________ ________________   
         Speaker of the House of Delegates.  